142 related articles for article (PubMed ID: 28470097)
1. Phenylbutyrate and β-cell function: contribution of histone deacetylases and ER stress inhibition.
Khan S; Komarya SK; Jena G
Epigenomics; 2017 May; 9(5):711-720. PubMed ID: 28470097
[TBL] [Abstract][Full Text] [Related]
2. Histone deacetylase inhibitors as antidiabetic agents: Advances and opportunities.
Sonthalia M; Roy BS; Chandrawanshi D; Ganesh GV; Jayasuriya R; Mohandas S; Rajagopal S; Ramkumar KM
Eur J Pharmacol; 2022 Nov; 935():175328. PubMed ID: 36257383
[TBL] [Abstract][Full Text] [Related]
3. Sodium phenylbutyrate inhibits Schwann cell inflammation via HDAC and NFκB to promote axonal regeneration and remyelination.
Yadav A; Huang TC; Chen SH; Ramasamy TS; Hsueh YY; Lin SP; Lu FI; Liu YH; Wu CC
J Neuroinflammation; 2021 Oct; 18(1):238. PubMed ID: 34656124
[TBL] [Abstract][Full Text] [Related]
4. Exploring histone deacetylases in type 2 diabetes mellitus: pathophysiological insights and therapeutic avenues.
Kumar KK; Aburawi EH; Ljubisavljevic M; Leow MKS; Feng X; Ansari SA; Emerald BS
Clin Epigenetics; 2024 Jun; 16(1):78. PubMed ID: 38862980
[TBL] [Abstract][Full Text] [Related]
5. 4-Phenylbutyric acid protects against neuronal cell death by primarily acting as a chemical chaperone rather than histone deacetylase inhibitor.
Mimori S; Ohtaka H; Koshikawa Y; Kawada K; Kaneko M; Okuma Y; Nomura Y; Murakami Y; Hamana H
Bioorg Med Chem Lett; 2013 Nov; 23(21):6015-8. PubMed ID: 24044874
[TBL] [Abstract][Full Text] [Related]
6. 4-phenylbutyrate exerts stage-specific effects on cardiac differentiation via HDAC inhibition.
Li Y; Weng X; Wang P; He Z; Cheng S; Wang D; Li X; Cheng G; Li T
PLoS One; 2021; 16(4):e0250267. PubMed ID: 33882103
[TBL] [Abstract][Full Text] [Related]
7. Histone deacetylase (HDAC) inhibition as a novel treatment for diabetes mellitus.
Christensen DP; Dahllöf M; Lundh M; Rasmussen DN; Nielsen MD; Billestrup N; Grunnet LG; Mandrup-Poulsen T
Mol Med; 2011; 17(5-6):378-90. PubMed ID: 21274504
[TBL] [Abstract][Full Text] [Related]
8. Sodium phenylbutyrate, a drug with known capacity to reduce endoplasmic reticulum stress, partially alleviates lipid-induced insulin resistance and beta-cell dysfunction in humans.
Xiao C; Giacca A; Lewis GF
Diabetes; 2011 Mar; 60(3):918-24. PubMed ID: 21270237
[TBL] [Abstract][Full Text] [Related]
9. Protective role of sodium butyrate, a HDAC inhibitor on beta-cell proliferation, function and glucose homeostasis through modulation of p38/ERK MAPK and apoptotic pathways: study in juvenile diabetic rat.
Khan S; Jena GB
Chem Biol Interact; 2014 Apr; 213():1-12. PubMed ID: 24530320
[TBL] [Abstract][Full Text] [Related]
10. Role of HDAC inhibitors in diabetes mellitus.
Makkar R; Behl T; Arora S
Curr Res Transl Med; 2020 Apr; 68(2):45-50. PubMed ID: 31477543
[TBL] [Abstract][Full Text] [Related]
11. Class IIa HDAC inhibition enhances ER stress-mediated cell death in multiple myeloma.
Kikuchi S; Suzuki R; Ohguchi H; Yoshida Y; Lu D; Cottini F; Jakubikova J; Bianchi G; Harada T; Gorgun G; Tai YT; Richardson PG; Hideshima T; Anderson KC
Leukemia; 2015 Sep; 29(9):1918-27. PubMed ID: 25801913
[TBL] [Abstract][Full Text] [Related]
12. Histone deacetylase inhibition decreases preference without affecting aversion for nicotine.
Pastor V; Host L; Zwiller J; Bernabeu R
J Neurochem; 2011 Feb; 116(4):636-45. PubMed ID: 21166804
[TBL] [Abstract][Full Text] [Related]
13. Valproic Acid Improves Glucose Homeostasis by Increasing Beta-Cell Proliferation, Function, and Reducing its Apoptosis through HDAC Inhibition in Juvenile Diabetic Rat.
Khan S; Jena G
J Biochem Mol Toxicol; 2016 Sep; 30(9):438-46. PubMed ID: 27079868
[TBL] [Abstract][Full Text] [Related]
14. The Emerging Role of HDACs: Pathology and Therapeutic Targets in Diabetes Mellitus.
Dewanjee S; Vallamkondu J; Kalra RS; Chakraborty P; Gangopadhyay M; Sahu R; Medala V; John A; Reddy PH; De Feo V; Kandimalla R
Cells; 2021 May; 10(6):. PubMed ID: 34071497
[TBL] [Abstract][Full Text] [Related]
15. The role of butyrate, a histone deacetylase inhibitor in diabetes mellitus: experimental evidence for therapeutic intervention.
Khan S; Jena G
Epigenomics; 2015; 7(4):669-80. PubMed ID: 26111036
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic therapy using the histone deacetylase inhibitor for increasing therapeutic gain in oral cancer: prevention of radiation-induced oral mucositis and inhibition of chemical-induced oral carcinogenesis.
Chung YL; Lee MY; Pui NN
Carcinogenesis; 2009 Aug; 30(8):1387-97. PubMed ID: 19351790
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of histone deacetylation with vorinostat does not prevent tunicamycin-mediated acute kidney injury.
Carlisle RE; Farooqi S; Zhang MC; Liu S; Lu C; Phan A; Brimble E; Dickhout JG
PLoS One; 2021; 16(11):e0260519. PubMed ID: 34847196
[TBL] [Abstract][Full Text] [Related]
18. 4-phenylbutyric acid promotes migration of gastric cancer cells by histone deacetylase inhibition-mediated IL-8 upregulation.
Shi X; Gong L; Liu Y; Hou K; Fan Y; Li C; Wen T; Qu X; Che X
Epigenetics; 2020; 15(6-7):632-645. PubMed ID: 31814524
[TBL] [Abstract][Full Text] [Related]
19. Protective effects of 4-phenylbutyrate derivatives on the neuronal cell death and endoplasmic reticulum stress.
Mimori S; Okuma Y; Kaneko M; Kawada K; Hosoi T; Ozawa K; Nomura Y; Hamana H
Biol Pharm Bull; 2012; 35(1):84-90. PubMed ID: 22223342
[TBL] [Abstract][Full Text] [Related]
20. An Isochemogenic Set of Inhibitors To Define the Therapeutic Potential of Histone Deacetylases in β-Cell Protection.
Wagner FF; Lundh M; Kaya T; McCarren P; Zhang YL; Chattopadhyay S; Gale JP; Galbo T; Fisher SL; Meier BC; Vetere A; Richardson S; Morgan NG; Christensen DP; Gilbert TJ; Hooker JM; Leroy M; Walpita D; Mandrup-Poulsen T; Wagner BK; Holson EB
ACS Chem Biol; 2016 Feb; 11(2):363-74. PubMed ID: 26640968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
